Small RNA Deep Sequencing Identifies a Unique miRNA Signature Released in Serum Exosomes in a Mouse Model of Sjögren's Syndrome

• Published in: Frontiers in immunology Vol. 11; p. 1475
• Main Authors: Kakan, Shruti Singh, Janga, Srikanth R., Cooperman, Benjamin, Craig, David W., Edman, Maria C., Okamoto, Curtis T., Hamm-Alvarez, Sarah F.
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 17.07.2020
• Subjects: Animals; Biomarkers - metabolism; Circulating MicroRNA - genetics; diagnostic miRNA biomarkers; Disease Models, Animal; Exosomes - genetics; Exosomes - metabolism; extracellular vesicles; Genetic Markers - genetics; High-Throughput Nucleotide Sequencing; Humans; Immunology; Inflammation - genetics; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; microRNA; piwi-RNA; Sjogren's Syndrome - diagnosis; Sjögren's Syndrome; small-RNA sequencing; Transcriptome; microRNA; diagnostic miRNA biomarkers; Sjögren's Syndrome; extracellular vesicles; small-RNA sequencing; piwi-RNA
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2020.01475

Sjögren's Syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration and loss of function of moisture-producing exocrine glands as well as systemic inflammation. SS diagnosis is cumbersome, subjective and complicated by manifestation of symptoms that overlap with those of other rheumatic and ocular diseases. Definitive diagnosis averages 4-5 years and this delay may lead to irreversible tissue damage. Thus, there is an urgent need for diagnostic biomarkers for earlier detection of SS. Extracellular vesicles called exosomes carry functional small non-coding RNAs which play a critical role in maintaining cellular homeostasis via transcriptional and translational regulation of mRNA. Alterations in levels of specific exosomal miRNAs may be predictive of disease status. Here, we have assessed serum exosomal RNA using next generation sequencing in a discovery cohort of the NOD mouse, a model of early-intermediate SS, to identify dysregulated miRNAs that may be indicative of SS. We found five miRNAs upregulated in serum exosomes of NOD mice with an adjusted < 0.05-miRNA-127-3p, miRNA-409-3p, miRNA-410-3p, miRNA-541-5p, and miRNA-540-5p. miRNAs 127-3p and 541-5p were also statistically significantly upregulated in a validation cohort of NOD mice. Pathway analysis and existing literature indicates that differential expression of these miRNAs may dysregulate pathways involved in inflammation. Future studies will apply these findings in a human cohort to understand how they are correlated with manifestations of SS as well as understanding their functional role in systemic autoimmunity specific to SS.